ResultsIQ

ResultsIQ › Latest results › Fermenta Biotech Limited

Fermenta Biotech Limited Q2 FY27 results deck summary

NSE: FERMENTA · BSE: 506414

Results deck of 6 Nov 2026, summarised by AI from the filing.

Q2 FY27 revenue ₹135.8 cr, up 8% QoQ but level YoY, as animal nutrition prices reset and net debt fell below ₹3 cr.

Key takeaways

  1. Q2 revenue Consolidated revenue ₹135.8 cr, up 0.1% YoY and up 8% QoQ, with EBITDA ₹23.2 cr and PAT ₹9.4 cr.
  2. Guidance VITADEE Green® capacity is expected from Q2FY28 and Calcifediol ready for regulatory approvals by end-FY27.
  3. Human Nutrition Human Nutrition revenue ₹163 cr in H1FY27, up 2% YoY, lifting its share of revenue to 62% from 57%.
  4. Animal nutrition Animal nutrition revenue fell to ₹22 cr from ₹46 cr, with volumes down 31% and realisations down 35% YoY.

Original filing on BSE

Fermenta Biotech Limited Q2 FY27 results

As filed: Revenue ₹117 cr, EBITDA ₹24.1 cr, PAT ₹14.0 cr, EBITDA margin 20.6%.

Not scored. No result for the same quarter last year.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%. Not scored. No result for the same quarter last year. Share price after the results: −11.7% in 30 days (Nifty 500: −3.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Fermenta Biotech Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.